Skip to main content

Advertisement

SpringerLink
Log in

Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer

  • Original Article
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. It is more common in developed countries and has become one of the main causes of death in some countries and regions. Currently, pancreatic cancer generally has a poor prognosis, partly due to the lack of symptoms in the early stages of pancreatic cancer. Therefore, most cases are diagnosed at advanced stage. With the continuous in-depth research of glycoproteomics in precision medical diagnosis, there have been some reports on quantitative analysis of cancer-related cells, plasma or tissues to find specific biomarkers for targeted therapy. This research is based on the developed complete N-linked glycopeptide database search engine GPSeeker, combined with liquid-mass spectrometry and stable diethyl isotope labeling, providing a benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers. With spectrum-level FDR ≤1%, 20,038 intact N-Glycopeptides corresponding to 4518 peptide backbones, 228 N-glycan monosaccharide compositions 1026 N-glycan putative structures, 4460 N-glycosites and 3437 intact N-glycoproteins were identified. With the criteria of ≥1.5-fold change and p value<0.05, 52 differentially expressed intact N-glycopeptides (DEGPs) were found in pancreatic cancer tussues relative to control, where 38 up-regulated and 14 down-regulated, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Blomme, B., Van Steenkiste, C., Callewaert, N., Van Vlierberghe, H.: Alteration of protein glycosylation in liver diseases. J. Hepatol. 50(3), 592–603 (2009). https://doi.org/10.1016/j.jhep.2008.12.010

    Article  CAS  PubMed  Google Scholar 

  2. Dennis, J., Laferte, S., Waghorne, C., Breitman, M., Kerbel, R.: Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science. 236(4801), 582–585 (1987). https://doi.org/10.1126/science.2953071

    Article  CAS  PubMed  Google Scholar 

  3. Kronewitter, S.R., de Leoz, M.L.A., Peacock, K.S., McBride, K.R., An, H.J., Miyamoto, S., Leiserowitz, G.S., Lebrilla, C.B.: Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J. Proteome Res. 9(10), 4952–4959 (2010). https://doi.org/10.1021/pr100202a

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lattová, E., Bryant, J., Skřičková, J., Zdráhal, Z., Popovič, M.: Efficient procedure for N-glycan analyses and detection of Endo H-like activity in human tumor specimens. J. Proteome Res. 15(8), 2777–2786 (2016). https://doi.org/10.1021/acs.jproteome.6b00346

    Article  CAS  PubMed  Google Scholar 

  5. Osumi, D., Takahashi, M., Miyoshi, E., Yokoe, S., Lee, S.H., Noda, K., Nakamori, S., Gu, J., Ikeda, Y., Kuroki, Y., Sengoku, K., Ishikawa, M., Taniguchi, N.: Core fucosylation of E-cadherin enhances cell–cell adhesion in human colon carcinoma WiDr cells. Cancer Sci. 100(5), 888–895 (2009). https://doi.org/10.1111/j.1349-7006.2009.01125.x

    Article  CAS  PubMed  Google Scholar 

  6. Pan, S., Brentnall, T.A., Chen, R.: Glycoproteins and glycoproteomics in pancreatic cancer. World J. Gastroenterol. 22(42), 9288–9299 (2016). https://doi.org/10.3748/wjg.v22.i42.9288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pan, S., Chen, R., Aebersold, R., Brentnall, T.A.: Mass spectrometry based Glycoproteomics—from a proteomics perspective. Mol. Cell. Proteomics. 10(1), R110.003251 (2011). https://doi.org/10.1074/mcp.R110.003251

    Article  PubMed  Google Scholar 

  8. Ruhaak, L.R., Miyamoto, S., Lebrilla, C.B.: Developments in the identification of glycan biomarkers for the detection of Cancer. Mol. Cell. Proteomics. 12(4), 846–855 (2013). https://doi.org/10.1074/mcp.R112.026799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M.J.: Cancer statistics, 2008. CA Cancer J. Clin. 58(2), 71–96 (2008). https://doi.org/10.3322/ca.2007.0010

    Article  PubMed  Google Scholar 

  10. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M.J.: Cancer statistics, 2009. CA Cancer J. Clin. 59(4), 225–249 (2009). https://doi.org/10.3322/caac.20006

    Article  PubMed  Google Scholar 

  11. Ballehaninna, U.K., Chamberlain, R.S.: The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J. Gastrointest. Oncol. 3(2), 105–119 (2011)

    Google Scholar 

  12. KIM, J.-E., LEE, K.T., LEE, J.K., PAIK, S.W., RHEE, J.C., CHOI, K.W.: Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J. Gastroenterol. Hepatol. 19(2), 182–186 (2004). https://doi.org/10.1111/j.1440-1746.2004.03219.x

    Article  PubMed  Google Scholar 

  13. Zhao, J., Simeone, D.M., Heidt, D., Anderson, M.A., Lubman, D.M.: Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J. Proteome Res. 5(7), 1792–1802 (2006). https://doi.org/10.1021/pr060034r

    Article  CAS  PubMed  Google Scholar 

  14. Sarrats, A., Saldova, R., Pla, E., Fort, E., Harvey, D.J., Struwe, W.B., de Llorens, R., Rudd, P.M., Peracaula, R.: Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics: Clin. Appl. 4(4), 432–448 (2010). https://doi.org/10.1002/prca.200900150

    Article  CAS  Google Scholar 

  15. Pan, S., Chen, R., Tamura, Y., Crispin, D.A., Lai, L.A., May, D.H., McIntosh, M.W., Goodlett, D.R., Brentnall, T.A.: Quantitative Glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J. Proteome Res. 13(3), 1293–1306 (2014). https://doi.org/10.1021/pr4010184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Park, H.-M., Hwang, M.P., Kim, Y.-W., Kim, K.-J., Jin, J.M., Kim, Y.H., Yang, Y.-H., Lee, K.H., Kim, Y.-G.: Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. Carbohydr. Res. 413, 5–11 (2015). https://doi.org/10.1016/j.carres.2015.04.019

    Article  CAS  PubMed  Google Scholar 

  17. Krishnan, S., Whitwell, H.J., Cuenco, J., Gentry-Maharaj, A., Menon, U., Pereira, S.P., Gaspari, M., Timms, J.F.: Evidence of altered glycosylation of serum proteins prior to pancreatic Cancer diagnosis. Int. J. Mol. Sci. 18(12), 2670 (2017)

    Article  PubMed Central  Google Scholar 

  18. Xiao, K., Tian, Z.: GPSeeker enables quantitative structural N-Glycoproteomics for site- and structure-specific characterization of differentially expressed N-glycosylation in hepatocellular carcinoma. J. Proteome Res. 18(7), 2885–2895 (2019). https://doi.org/10.1021/acs.jproteome.9b00191

    Article  CAS  PubMed  Google Scholar 

  19. Wang, Y., Xiao, K., Tian, Z.: Quantitative N-glycoproteomics using stable isotopic diethyl labeling. Talanta. 219, 121359 (2020). https://doi.org/10.1016/j.talanta.2020.121359

    Article  CAS  PubMed  Google Scholar 

  20. Xiao, K., Tian, Z.: Site- and structure-specific quantitative N-Glycoproteomics using RPLC-pentaHILIC separation and the intact N-Glycopeptide search engine GPSeeker. Curr. Protoc. Protein Sci. 97(1), e94 (2019). https://doi.org/10.1002/cpps.94

    Article  CAS  PubMed  Google Scholar 

  21. Wang, Y., Xu, F., Chen, Y., Tian, Z.: A quantitative N-glycoproteomics study of cell-surface N-glycoprotein markers of MCF-7/ADR cancer stem cells. Anal. Bioanal. Chem. 412(11), 2423–2432 (2020). https://doi.org/10.1007/s00216-020-02453-7

    Article  CAS  PubMed  Google Scholar 

  22. Wang, Y., Xu, F., Xiao, K., Chen, Y., Tian, Z.: Site- and structure-specific characterization of N-glycoprotein markers of MCF-7 cancer stem cells using isotopic-labelling quantitative N-glycoproteomics. Chem. Commun. 55(55), 7934–7937 (2019). https://doi.org/10.1039/C9CC04114A

    Article  CAS  Google Scholar 

  23. Xu, F., Wang, Y., Xiao, K., Hu, Y., Tian, Z., Chen, Y.: Quantitative site- and structure-specific N-glycoproteomics characterization of differential N-glycosylation in MCF-7/ADR cancer stem cells. Clin. Proteomics. 17(1), 3 (2020). https://doi.org/10.1186/s12014-020-9268-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Koehler, C.J., Arntzen, M.Ø., Thiede, B.: The impact of carbon-13 and deuterium on relative quantification of proteins using stable isotope diethyl labeling. Rapid Commun. Mass Spectrom. 29(9), 830–836 (2015). https://doi.org/10.1002/rcm.7170

    Article  CAS  PubMed  Google Scholar 

  25. Chen, Z., Yu, Q., Hao, L., Liu, F., Johnson, J., Tian, Z., Kao, W.J., Xu, W., Li, L.: Site-specific characterization and quantitation of N-glycopeptides in PKM2 knockout breast cancer cells using DiLeu isobaric tags enabled by electron-transfer/higher-energy collision dissociation (EThcD). Analyst. 143(11), 2508–2519 (2018). https://doi.org/10.1039/C8AN00216A

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Miyauchi, E., Furuta, T., Ohtsuki, S., Tachikawa, M., Uchida, Y., Sabit, H., Obuchi, W., Baba, T., Watanabe, M., Terasaki, T., Nakada, M.: Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PLoS One. 13(3), e0193799 (2018). https://doi.org/10.1371/journal.pone.0193799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhou, Q., Andersson, R., Hu, D., Bauden, M., Kristl, T., Sasor, A., Pawłowski, K., Pla, I., Hilmersson, K.S., Zhou, M., Lu, F., Marko-Varga, G., Ansari, D.: Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue. EBioMedicine. 43, 282–294 (2019). https://doi.org/10.1016/j.ebiom.2019.04.008

    Article  PubMed  PubMed Central  Google Scholar 

  28. Tralhão, J.G., Schaefer, L., Micegova, M., Evaristo, C., Schönherr, E., Kayal, S., Veiga-Fernandes, H., Danel, C., Iozzo, R.V., Kresse, H., Lemarchand, P.: In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J. 17(3), 464–466 (2003). https://doi.org/10.1096/fj.02-0534fje

    Article  CAS  PubMed  Google Scholar 

  29. Nash, M.A., Loercher, A.E., Freedman, R.S.: In vitro growth inhibition of ovarian Cancer cells by Decorin: synergism of action between Decorin and carboplatin. Cancer Res. 59(24), 6192–6196 (1999)

    CAS  PubMed  Google Scholar 

  30. Jörg, K., Nathalia, A.G., Fabio, F.M., Pascal, B., Thomas, G., Irene, E., Max, G.B., Markus, W.B., Helmut, F.: Overexpressed Decorin in Pancreatic Cancer. Clin. Cancer. Res.10(14):4776-4783 (2004). https://doi.org/10.1158/1078-0432.CCR-1190-03

  31. Johnson, M.D., Torri, J.A., Lippman, M.E., Dickson, R.B.: The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res. 53(4), 873–877 (1993)

    CAS  PubMed  Google Scholar 

  32. Cheng, A.-L., Huang, W.-G., Chen, Z.-C., Zhang, P.-F., Li, M.-Y., Li, F., Li, J.-L., Li, C., Yi, H., Peng, F., Duan, C.-J., Xiao, Z.-Q.: Identificating Cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J. Proteome Res. 7(6), 2415–2426 (2008). https://doi.org/10.1021/pr7008548

    Article  CAS  PubMed  Google Scholar 

  33. Roth, U., Razawi, H., Hommer, J., Engelmann, K., Schwientek, T., Müller, S., Baldus, S.E., Patsos, G., Corfield, A.P., Paraskeva, C., Hanisch, F.-G.: Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma. Proteomics. 10(2), 194–202 (2010). https://doi.org/10.1002/pmic.200900614

    Article  CAS  PubMed  Google Scholar 

  34. Selicharova, I., Sanda, M., Mladkova, J., Ohri, S.S., Vashishta, A., Fusek, M., Jiracek, J., Vetvicka, V.: 2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231. Oncol. Rep. 19(5), 1237–1244 (2008). https://doi.org/10.3892/or.19.5.1237

    Article  CAS  PubMed  Google Scholar 

  35. Bossard, N., Descotes, F., Bremond, A.G., Bobin, Y., De Saint Hilaire, P., Golfier, F., Awada, A., Mathevet, P.M., Berrerd, L., Barbier, Y., Estève, J.: Keeping data continuous when analyzing the prognostic impact of a tumor marker: An example with Cathepsin D in breast Cancer. Breast Cancer Res. Treat. 82(1), 47–59 (2003). https://doi.org/10.1023/B:BREA.0000003919.75055.e8

    Article  CAS  PubMed  Google Scholar 

  36. Kirana, C., Shi, H., Laing, E., Hood, K., Miller, R., Bethwaite, P., Keating, J., Jordan, T.W., Hayes, M., Stubbs, R.: Cathepsin D expression in colorectal Cancer: from proteomic discovery through validation using Western blotting, immunohistochemistry, and tissue microarrays. Int J Proteomics. 2012, 245819–245819 (2012). https://doi.org/10.1155/2012/245819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Shin, I.Y., Sung, N.Y., Lee, Y.S., Kwon, T.S., Si, Y., Lee, Y.S., Oh, S.T., Lee, I.K.: The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67. Gut Liver. 8(1), 13–23 (2014). https://doi.org/10.5009/gnl.2014.8.1.13

    Article  PubMed  Google Scholar 

  38. Hui-juan, Z., Xiao-wei, Z., Ling, Q., Hong-chao, L., Wen-jing, C., Feng, L., Cai-yun, J.: Clinical significance and correlation with prognosis of novel glycosylation isoform of cathepsin D expression in lung cancer. Acta Anat Sin. 49(2), 191–197 (2018). https://doi.org/10.16098/j.issn.0529-1356.2018.02.009

    Article  Google Scholar 

  39. Kang, J., Yu, Y., Jeong, S., Lee, H., Heo, H.J., Park, J.J., Na, H.S., Ko, D.S., Kim, Y.H.: Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis. Ther. Adv. Med. Oncol. 12, 1758835920927838–1758835920927838 (2020). https://doi.org/10.1177/1758835920927838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Whiteman, H.J., Weeks, M.E., Dowen, S.E., Barry, S., Timms, J.F., Lemoine, N.R., Crnogorac-Jurcevic, T.: The role of S100P in the invasion of pancreatic Cancer cells is mediated through cytoskeletal changes and regulation of Cathepsin D. cancer Res. 67(18), 8633–8642 (2007). https://doi.org/10.1158/0008-5472.can-07-0545

  41. Dumartin, L., Whiteman, H.J., Weeks, M.E., Hariharan, D., Dmitrovic, B., Iacobuzio-Donahue, C.A., Brentnall, T.A., Bronner, M.P., Feakins, R.M., Timms, J.F., Brennan, C., Lemoine, N.R., Crnogorac-Jurcevic, T.: AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. cancer Res. 71(22), 7091–7102 (2011). https://doi.org/10.1158/0008-5472.CAN-11-1367

  42. Ivry, S.L., Knudsen, G.M., Caiazza, F., Sharib, J.M., Jaradeh, K., Ravalin, M., O’Donoghue, A.J., Kirkwood, K.S., Craik, C.S.: The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts. Biol. Chem. 400(12), 1629–1638 (2019). https://doi.org/10.1515/hsz-2019-0103

    Article  CAS  PubMed  Google Scholar 

  43. Nastase, M.V., Young, M.F., Schaefer, L.: Biglycan: a multivalent proteoglycan providing structure and signals. J. Histochem. Cytochem. 60(12), 963–975 (2012). https://doi.org/10.1369/0022155412456380

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hu, L., Zang, M.-D., Wang, H.-X., Li, J.-F., Su, L.-P., Yan, M., Li, C., Yang, Q.-M., Liu, B.-Y., Zhu, Z.-G.: Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway. Mol. Oncol. 10(9), 1473–1484 (2016). https://doi.org/10.1016/j.molonc.2016.08.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Schaefer, L., Tredup, C., Gubbiotti, M.A., Iozzo, R.V.: Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. FASEB J. 284(1), 10–26 (2017). https://doi.org/10.1111/febs.13963

    Article  CAS  Google Scholar 

  46. Xing, X., Gu, X., Ma, T., Ye, H.: Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer. Tumor Biol. 36(3), 1773–1780 (2015). https://doi.org/10.1007/s13277-014-2779-y

    Article  CAS  Google Scholar 

  47. Gu, X., Ma, Y., Xiao, J., Zheng, H., Song, C., Gong, Y., Xing, X.: Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers. Clin. Exp. Med. 12(3), 195–199 (2012). https://doi.org/10.1007/s10238-011-0155-4

    Article  CAS  PubMed  Google Scholar 

  48. Liu, Y., Li, W., Li, X., Tai, Y., Lü, Q., Yang, N., Jiang, J.: Expression and significance of biglycan in endometrial cancer. Arch. Gynecol. Obstet. 289(3), 649–655 (2014). https://doi.org/10.1007/s00404-013-3017-3

    Article  CAS  PubMed  Google Scholar 

  49. Niedworok, C., Röck, K., Kretschmer, I., Freudenberger, T., Nagy, N., Szarvas, T., vom Dorp, F., Reis, H., Rübben, H., Fischer, J.W.: Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer. PLoS One. 8(11), e80084 (2013). https://doi.org/10.1371/journal.pone.0080084

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Wang, B., Li, G.-X., Zhang, S.-G., Wang, Q., Wen, Y.-G., Tang, H.-M., Zhou, C.-Z., Xing, A.-Y., Fan, J.-W., Yan, D.-W., Qiu, G.-Q., Yu, Z.-H., Peng, Z.-H.: Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp. Biol. Med. 236(11), 1247–1253 (2011). https://doi.org/10.1258/ebm.2011.011124

    Article  CAS  Google Scholar 

  51. Zhao, S.F., Yin, X.J., Zhao, W.J., Liu, L.C., Wang, Z.P.: Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers. Oncol. Lett. 19(3), 1673–1682 (2020). https://doi.org/10.3892/ol.2020.11266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Yamamoto, K., Ohga, N., Hida, Y., Maishi, N., Kawamoto, T., Kitayama, K., Akiyama, K., Osawa, T., Kondoh, M., Matsuda, K., Onodera, Y., Fujie, M., Kaga, K., Hirano, S., Shinohara, N., Shindoh, M., Hida, K.: Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br. J. Cancer. 106(6), 1214–1223 (2012). https://doi.org/10.1038/bjc.2012.59

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Weber, C.K., Sommer, G., Michl, P., Fensterer, H., Weimer, M., Gansauge, F., Leder, G., Adler, G., Gress, T.M.: Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology. 121(3), 657–667 (2001). https://doi.org/10.1053/gast.2001.27222

    Article  CAS  PubMed  Google Scholar 

  54. Aprile, G., Avellini, C., Reni, M., Mazzer, M., Foltran, L., Rossi, D., Cereda, S., Iaiza, E., Fasola, G., Piga, A.: Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma. Tumor Biol. 34(1), 131–137 (2013). https://doi.org/10.1007/s13277-012-0520-2

    Article  CAS  Google Scholar 

  55. Otterbein, H., Lehnert, H., Ungefroren, H.: Negative control of cell migration by Rac1b in highly metastatic pancreatic Cancer cells is mediated by sequential induction of nonactivated Smad3 and Biglycan. Cancers. 11(12), 1959 (2019). https://doi.org/10.3390/cancers11121959

    Article  CAS  PubMed Central  Google Scholar 

  56. Maliniemi, P., Carlsson, E., Kaukola, A., Ovaska, K., Niiranen, K., Saksela, O., Jeskanen, L., Hautaniemi, S., Ranki, A.: NAV3 copy number changes and target genes in basal and squamous cell cancers. Exp. Dermatol. 20(11), 926–931 (2011). https://doi.org/10.1111/j.1600-0625.2011.01358.x

    Article  CAS  PubMed  Google Scholar 

  57. Cohen-Dvashi, H., Ben-Chetrit, N., Russell, R., Carvalho, S., Lauriola, M., Nisani, S., Mancini, M., Nataraj, N., Kedmi, M., Roth, L., Köstler, W., Zeisel, A., Yitzhaky, A., Zylberg, J., Tarcic, G., Eilam, R., Wigelman, Y., Will, R., Lavi, S., Porat, Z., Wiemann, S., Ricardo, S., Schmitt, F., Caldas, C., Yarden, Y.: Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression. EMBO Mol. Med. 7(3), 299–314 (2015). https://doi.org/10.15252/emmm.201404134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Duarte, B.D.P., Bonatto, D.: The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research. J. Cancer Res. Clin. Oncol. 144(12), 2319–2328 (2018). https://doi.org/10.1007/s00432-018-2739-9

    Article  CAS  PubMed  Google Scholar 

  59. Schwab, M.: Amplification of oncogenes in human cancer cells. Bioessays. 20(6), 473–479 (1998)

    Article  CAS  PubMed  Google Scholar 

  60. Zhu, J., Xiong, G., Fu, H., Evers, B.M., Zhou, B.P., Xu, R.: Chaperone Hsp47 drives malignant growth and invasion by modulating an ECM gene network. Cancer Res. 75(8), 1580–1591 (2015). https://doi.org/10.1158/0008-5472.can-14-1027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Poschmann, G., Sitek, B., Sipos, B., Ulrich, A., Wiese, S., Stephan, C., Warscheid, B., Klöppel, G., Vander Borght, A., Ramaekers, F.C.S., Meyer, H.E., Stühler, K.: Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol. Cell. Proteomics. 8(5), 1105–1116 (2009). https://doi.org/10.1074/mcp.M800422-MCP200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Thierolf, M., Hagmann, M.-L., Pfeffer, M., Berntenis, N., Wild, N., Roeßler, M., Palme, S., Karl, J., Bodenmüller, H., Rüschoff, J., Rossol, S., Rohr, G., Rösch, W., Friess, H., Eickhoff, A., Jauch, K.-W., Langen, H., Zolg, W., Tacke, M.: Towards a comprehensive proteome of normal and malignant human colon tissue by 2-D-LC-ESI-MS and 2-DE proteomics and identification of S100A12 as potential cancer biomarker. Proteomics: Clin. Appl. 2(1), 11–22 (2008). https://doi.org/10.1002/prca.200780046

    Article  CAS  Google Scholar 

  63. Yamamoto, N., Kinoshita, T., Nohata, N., Yoshino, H., Itesako, T., Fujimura, L., Mitsuhashi, A., Usui, H., Enokida, H., Nakagawa, M., Shozu, M., Seki, N.: Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. Int. J. Oncol. 43(6), 1855–1863 (2013). https://doi.org/10.3892/ijo.2013.2145

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Zhang, X., Yang, J.-J., Kim, Y.S., Kim, K.-Y., Ahn, W.S., Yang, S.: An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. Int. J. Oncol. 36(2), 405–414 (2010). https://doi.org/10.3892/ijo_00000513

    Article  CAS  PubMed  Google Scholar 

  65. Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Sohn, T.A., Argani, P., Meyer, R., Yeo, C.J., Cameron, J.L., Goggins, M., Kern, S.E., Ashfaq, R., Hruban, R.H., Wilentz, R.E.: Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin Fascin homolog and heat shock protein 47. Am. J. Clin. Pathol. 118(1), 52–59 (2002). https://doi.org/10.1309/3pam-p5wl-2lv0-r4eg

    Article  CAS  PubMed  Google Scholar 

  66. Cao, D., Maitra, A., Saavedra, J.-A., Klimstra, D.S., Adsay, N.V., Hruban, R.H.: Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod. Pathol. 18(6), 752–761 (2005). https://doi.org/10.1038/modpathol.3800363

    Article  CAS  PubMed  Google Scholar 

  67. Shimada, H., Kuboshima, M., Shiratori, T., Nabeya, Y., Takeuchi, A., Takagi, H., Nomura, F., Takiguchi, M., Ochiai, T., Hiwasa, T.: Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma. Int. J. Oncol. 30(1), 97–103 (2007). https://doi.org/10.3892/ijo.30.1.97

    Article  CAS  PubMed  Google Scholar 

  68. Sattar, M., Majid, A.: Lung Cancer classification models using discriminant information of mutated genes in protein amino acids sequences. Arabian J. Sci. Eng. 44(4), 3197–3211 (2019). https://doi.org/10.1007/s13369-018-3468-8

    Article  CAS  Google Scholar 

  69. Ma, H., Song, B., Guo, S., Li, G., Jin, G.: Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing. Cancer Biomark. 27, 389–397 (2020). https://doi.org/10.3233/CBM-190236

    Article  CAS  PubMed  Google Scholar 

  70. Kasthuri, R.S., Taubman, M.B., Mackman, N.: Role of tissue factor in cancer. J. Clin. Oncol. 27(29), 4834–4838 (2009). https://doi.org/10.1200/JCO.2009.22.6324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. van den Berg, Y.W., Osanto, S., Reitsma, P.H., Versteeg, H.H.: The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood. 119(4), 924–932 (2012). https://doi.org/10.1182/blood-2011-06-317685

    Article  CAS  PubMed  Google Scholar 

  72. Dammacco, F., Vacca, A., Procaccio, P., Ria, R., Marech, I., Racanelli, V.: Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine. Clin. Exp. Med. 13(2), 85–97 (2013). https://doi.org/10.1007/s10238-013-0230-0

    Article  CAS  PubMed  Google Scholar 

  73. Haas, S.L., Jesnowski, R., Steiner, M., Hummel, F., Ringel, J., Burstein, C., Nizze, H., Liebe, S., Löhr, J.M.: Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J. Gastroenterol. 12(30), 4843–4849 (2006). https://doi.org/10.3748/wjg.v12.i30.4843

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Bieker, R., Kessler, T., Schwöppe, C., Padró, T., Persigehl, T., Bremer, C., Dreischalück, J., Kolkmeyer, A., Heindel, W., Mesters, R.M., Berdel, W.E.: Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience. Blood. 113(20), 5019–5027 (2009). https://doi.org/10.1182/blood-2008-04-150318

    Article  CAS  PubMed  Google Scholar 

  75. Ferreira, C.A., Ehlerding, E.B., Rosenkrans, Z.T., Jiang, D., Sun, T., Aluicio-Sarduy, E., Engle, J.W., Ni, D., Cai, W.: 86/90Y-labeled monoclonal antibody targeting tissue factor for pancreatic Cancer Theranostics. Mol. Pharm. 17(5), 1697–1705 (2020). https://doi.org/10.1021/acs.molpharmaceut.0c00127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Jaffe, E.A., Ruggiero, J.T., Leung, L.K., Doyle, M.J., McKeown-Longo, P.J., Mosher, D.F.: Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 80(4), 998–1002 (1983). https://doi.org/10.1073/pnas.80.4.998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Phillips, D.R., Jennings, L.K., Prasanna, H.R.: Ca2+−mediated association of glycoprotein G (thrombinsensitive protein, thrombospondin) with human platelets. J. Biol. Chem. 255(24), 11629–11632 (1980)

    Article  CAS  PubMed  Google Scholar 

  78. Simantov, R., Febbraio, M., Crombie, R., Asch, A.S., Nachman, R.L., Silverstein, R.L.: Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J. Clin. Invest. 107(1), 45–52 (2001). https://doi.org/10.1172/JCI9061

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Pengfei, W., Zheng, Z., Caiji, L., Jiali, W., Wenwen, X., Wenqing, M., Qian, X., Huidi, L., Shu-Lin, L.: Thrombospondin-1 as a potential therapeutic target: multiple roles in cancers. Curr. Pharm. Des. 26(18), 2116–2136 (2020). https://doi.org/10.2174/1381612826666200128091506

    Article  CAS  Google Scholar 

  80. Albo, D., Berger, D.H., Wang, T.N., Hu, X., Rothman, V., Tuszynski, G.P.: Thrombospondin-1 and transforming growth factor-betal promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Surgery. 122(2), 493–500 (1997). https://doi.org/10.1016/S0039-6060(97)90043-X

    Article  CAS  PubMed  Google Scholar 

  81. Bocci, G., Fioravanti, A., Orlandi, P., Di Desidero, T., Natale, G., Fanelli, G., Viacava, P., Naccarato, A.G., Francia, G., Danesi, R.: Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1. Neoplasia (New York, N.Y.). 14(9), 833–845 (2012). https://doi.org/10.1593/neo.12772

    Article  CAS  Google Scholar 

  82. Qian, X., Rothman, V.L., Nicosia, R.F., Tuszynski, G.P.: Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production. Pathol. Oncol. Res. 7(4), 251–259 (2001). https://doi.org/10.1007/BF03032381

    Article  CAS  PubMed  Google Scholar 

  83. Laklai, H., Laval, S., Dumartin, L., Rochaix, P., Hagedorn, M., Bikfalvi, A., Le Guellec, S., Delisle, M.-B., Schally, A.V., Susini, C., Pyronnet, S., Bousquet, C.: Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer. Proc. Natl. Acad. Sci. U. S. A. 106(42), 17769–17774 (2009). https://doi.org/10.1073/pnas.0908674106

    Article  PubMed  PubMed Central  Google Scholar 

  84. Zhang, X., Connolly, C., Duquette, M., Lawler, J., Parangi, S.: Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Lett. 247(1), 143–149 (2007). https://doi.org/10.1016/j.canlet.2006.04.003

    Article  CAS  PubMed  Google Scholar 

  85. Nie, S., Lo, A., Wu, J., Zhu, J., Tan, Z., Simeone, D.M., Anderson, M.A., Shedden, K.A., Ruffin, M.T., Lubman, D.M.: Glycoprotein biomarker panel for pancreatic Cancer discovered by quantitative proteomics analysis. J. Proteome Res. 13(4), 1873–1884 (2014). https://doi.org/10.1021/pr400967x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Choi, S.H., Tamura, K., Khajuria, R.K., Bhere, D., Nesterenko, I., Lawler, J., Shah, K.: Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas. Mol. Ther. 23(2), 235–243 (2015). https://doi.org/10.1038/mt.2014.214

    Article  CAS  PubMed  Google Scholar 

  87. Fu, X., Zhu, B.T.: Human pancreas-specific protein disulfide isomerase homolog (PDIp) is redox-regulated through formation of an inter-subunit disulfide bond. Arch. Biochem. Biophys. 485(1), 1–9 (2009). https://doi.org/10.1016/j.abb.2008.12.021

    Article  CAS  PubMed  Google Scholar 

  88. Fu, X.-M., Zhu, B.T.: Human pancreas-specific protein disulfide isomerase homolog (PDIp) is an intracellular estrogen-binding protein that modulates estrogen levels and actions in target cells. J. Steroid Biochem. Mol. Biol. 115(1–2), 20–29 (2009). https://doi.org/10.1016/j.jsbmb.2009.02.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Fu, X.-M., Dai, X., Ding, J., Zhu, B.T.: Pancreas-specific protein disulfide isomerase has a cell type-specific expression in various mouse tissues and is absent in human pancreatic adenocarcinoma cells: implications for its functions. J. Mol. Histol. 40(3), 189–199 (2009). https://doi.org/10.1007/s10735-009-9230-5

    Article  CAS  PubMed  Google Scholar 

  90. Ozawa, K., Kuwabara, K., Tamatani, M., Takatsuji, K., Tsukamoto, Y., Kaneda, S., Yanagi, H., Stern, D.M., Eguchi, Y., Tsujimoto, Y., Ogawa, S., Tohyama, M.: 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 274(10), 6397–6404 (1999). https://doi.org/10.1074/jbc.274.10.6397

    Article  CAS  PubMed  Google Scholar 

  91. Asahi, H., Koshida, K., Hori, O., Ogawa, S., Namiki, M.: Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. BJU Int. 90, 462–466 (2002). https://doi.org/10.1046/j.1464-410X.2002.02915.x

    Article  CAS  PubMed  Google Scholar 

  92. Tsukamoto, Y., Kuwabara, K., Hirota, S., Kawano, K., Yoshikawa, K., Ozawa, K., Kobayashi, T., Yanagi, H., Stern, D.M., Tohyama, M., Kitamura, Y., Ogawa, S.: Expression of the 150-kd oxygen-regulated protein in human breast cancer. Lab. Investig. 78(6), 699–706 (1998)

    CAS  PubMed  Google Scholar 

  93. Zhou, Q., Andersson, R., Hu, D., Bauden, M., Sasor, A., Bygott, T., PawŁowski, K., Pla, I., Marko-Varga, G., Ansari, D.: Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis. Transl. Res. 212, 67–79 (2019). https://doi.org/10.1016/j.trsl.2019.06.003

    Article  CAS  PubMed  Google Scholar 

  94. Wang, Y., Wu, W., Zhu, M., Wang, C., Shen, W., Cheng, Y., Geng, L., Li, Z., Zhang, J., Dai, J., Ma, H., Chen, L., Hu, Z., Jin, G., Shen, H.: Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes. Int. J. Cancer. 142(8), 1602–1610 (2018). https://doi.org/10.1002/ijc.31182

    Article  CAS  PubMed  Google Scholar 

  95. Castro-Piedras, I., Sharma, M., den Bakker, M., Molehin, D., Martinez, E.G., Vartak, D., Pruitt, W.M., Deitrick, J., Almodovar, S., Pruitt, K.: DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells. Oncotarget. 9(86), 35639–35654 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  96. Chen, X.Q., Jiang, J., Wang, X.T., Zhang, C.L., Ji, A.Y., Chen, X.J.: Role and mechanism of Dvl3 in the esophageal squamous cell carcinoma. Eur. Rev. Med. Pharmacol. Sci. 22(22), 7716–7725 (2018). https://doi.org/10.26355/eurrev_201811_16393

    Article  PubMed  Google Scholar 

  97. Kafka, A., Tomas, D., Lechpammer, M., Gabud, T., Pažanin, L., Pećina-Šlaus, N.: Expression levels and localizations of DVL3 and sFRP3 in Glioblastoma. Dis. Markers. 2017(9253495), 1–10 (2017). https://doi.org/10.1155/2017/9253495

    Article  CAS  Google Scholar 

  98. Barat, S., Chen, X., Cuong Bui, K., Bozko, P., Götze, J., Christgen, M., Krech, T., Malek, N.P., Plentz, R.R.: Gamma-Secretase inhibitor IX (GSI) impairs concomitant activation of notch and Wnt-Beta-catenin pathways in CD44+ gastric Cancer stem cells. Stem Cells Transl. Med. 6(3), 819–829 (2017). https://doi.org/10.1002/sctm.16-0335

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Pai, V.C., Hsu, C.-C., Chan, T.-S., Liao, W.-Y., Chuu, C.-P., Chen, W.-Y., Li, C.-R., Lin, C.-Y., Huang, S.-P., Chen, L.-T., Tsai, K.K.: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Oncogene. 38(8), 1340–1353 (2019). https://doi.org/10.1038/s41388-018-0497-4

    Article  CAS  PubMed  Google Scholar 

  100. Rodriguez-Mora, O., LaHair, M.M., Howe, C.J., McCubrey, J.A., Franklin, R.A.: Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy. Expert Opin. Ther. Targets. 9(4), 791–808 (2005). https://doi.org/10.1517/14728222.9.4.791

    Article  CAS  PubMed  Google Scholar 

  101. Tadic, M., Stoos-Veic, T., Kujundzic, M., Turcic, P., Aralica, G., Boskoski, I.: Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma. Eur. J. Gastroenterol. Hepatol. 32(4), 496–500 (2020). https://doi.org/10.1097/meg.0000000000001696

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was financially supported by National Natural Science Foundation of China (21775110, 22074105) and Shanghai Science and Technology Commission (14DZ2261100).

Availability of data and material

The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.

Author information

Authors and Affiliations

  1. School of Chemical Science & Engineering, Shanghai Key Laboratory of Chemical Assessment and Sustainability, Tongji University, Shanghai, 200092, China

    Haoran Lu, Kaijie Xiao & Zhixin Tian

Authors
  1. Haoran Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaijie Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhixin Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhixin Tian.

Ethics declarations

Ethical approval

This study was performed in compliance with the Helsinki Declaration on ethical principles for handling human tissue specimens, with all China national regulations and requirements. Written informed consent was obtained from participants. Ethical permission for the study was granted by the ethics committees at Tongji University (Shanghai, China) and Changhai Hospital (Shanghai, China).

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 1842 kb)

ESM 2

(XLSX 2583 kb)

ESM 3

(XLSX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, H., Xiao, K. & Tian, Z. Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer. Glycoconj J 38, 213–231 (2021). https://doi.org/10.1007/s10719-021-09994-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-021-09994-8

Keywords

Search

Navigation